Nab-PTX, Ifosfamide and Cisplatin in the Treatment of Pediatric Extracranial Germ Cell Tumor.
Status:
Not yet recruiting
Trial end date:
2024-05-10
Target enrollment:
Participant gender:
Summary
The purpose is to evaluate the effectiveness and safety of albumin-bound paclitaxel
(nab-PTX), ifosfamide and cisplatin in the treatment of children patients with advanced,
recurrent or refractory extracranial germ cell tumor.